The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

Share Price Information for Walker Crips (WCW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.50
Bid: 20.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.00%)
Open: 20.50
High: 20.50
Low: 20.50
Prev. Close: 20.50
WCW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Clinical Computing

3 Mar 2017 15:13

RNS Number : 5224Y
Walker Crips Group plc
03 March 2017
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Walker Crips Stockbrokers Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Clinical Computing plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

2nd March 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,567,563

2.01

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

2,567,563

2.01

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

2nd March 2017

Contact name:

Michael Callicott

Telephone number:

020 3100 8685

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETMMGGFKFMGNZM
Date   Source Headline
14th Dec 20164:13 pmRNSDirector/PDMR Shareholding
28th Nov 20164:36 pmRNSDirector/PDMR Shareholding
18th Nov 20164:00 pmRNSHalf-year Report
18th Nov 20164:00 pmRNSDirectorate Change
1st Nov 201611:59 amRNSDirector/PDMR Shareholding
1st Nov 201611:59 amRNSDirector/PDMR Shareholding
1st Nov 201611:58 amRNSDirector/PDMR Shareholding
1st Nov 201611:58 amRNSDirector/PDMR Shareholding
1st Nov 201611:57 amRNSDirector/PDMR Shareholding
1st Nov 201611:55 amRNSDirector/PDMR Shareholding
17th Oct 20167:00 amRNSIssue of Equity
28th Sep 201612:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:59 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:58 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:57 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:55 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:55 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:54 pmRNSDirector/PDMR Shareholding
23rd Sep 20164:53 pmRNSDirector/PDMR Shareholding
22nd Sep 20169:44 amRNSAppointment of Director
23rd Aug 20165:28 pmRNSDirector/PDMR Shareholding
23rd Aug 20164:21 pmRNSDirector/PDMR Shareholding
19th Aug 20165:41 pmRNSDirector/PDMR Shareholding
4th Aug 201611:40 amRNSResult of AGM
27th Jul 20168:35 amRNSDirector/PDMR Shareholding
30th Jun 20167:00 amRNSWalker Crips Group plc Annual Financial Results
28th Jun 20169:56 amRNSDirector/PDMR Shareholding
22nd Jun 20161:25 pmRNSHolding(s) in Company
1st Jun 20163:45 pmRNSForm 8.3 - Sweett Group PLC
1st Jun 201611:10 amRNSReplacement - Holding(s) in Company
1st Jun 20169:59 amRNSHolding(s) in Company
25th May 20164:25 pmRNSDirector/PDMR Shareholding
10th May 20165:09 pmRNSHolding(s) in Company
9th May 20164:25 pmRNSDirector/PDMR Shareholding
21st Apr 20162:00 pmRNSReplacement: Issue of Equity
21st Apr 20167:00 amRNSIssue of Equity
24th Mar 20163:46 pmRNSDirector/PDMR Shareholding
7th Mar 20163:49 pmRNSDirector/PDMR Shareholding
25th Feb 201610:31 amRNSDirector/PDMR Shareholding
2nd Feb 20162:35 pmRNSDirector/PDMR Shareholding
27th Jan 20163:14 pmRNSIssue of Equity and Total Voting Rights
22nd Jan 20163:23 pmRNSDirector/PDMR Shareholding
18th Dec 20154:27 pmRNSDirector/PDMR Shareholding
15th Dec 20157:00 amRNSDirector/PDMR Shareholding
3rd Dec 20157:00 amRNSIssue of Equity and Total Voting Rights
24th Nov 20155:15 pmRNSDirector/PDMR Shareholding
19th Nov 20157:00 amRNSResults for the six months ended 30 September 2015
29th Oct 20156:23 pmRNSDirector/PDMR Shareholding
15th Oct 20153:45 pmRNSBlocklisting Interim Review
25th Sep 20154:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.